Oriza Ventures appeared to be the VC, which was created in 2015. The main office of represented VC is situated in the Santa Clara. The company was established in North America in United States.
Among the most popular portfolio startups of the fund, we may highlight Atrium LTS, Drive.ai, Bolt. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Besides, a startup needs to be aged 2-3 years to get the investment from the fund. The fund has no exact preference in some founders of portfolio startups. If startup sums 5+ of the founder, the chance for it to be financed is low. Among the most popular fund investment industries, there are Software, Mobile.
The usual cause for the fund is to invest in rounds with 4-5 partakers. Despite the Oriza Ventures, startups are often financed by ff Venture Capital, Correlation Ventures, Voyager Capital. The meaningful sponsors for the fund in investment in the same round are Northern Light Venture Capital, StartX (Stanford-StartX Fund), Plug and Play. In the next rounds fund is usually obtained by Plug and Play, StartX (Stanford-StartX Fund), Samsung NEXT.
Deals in the range of 10 - 50 millions dollars are the general things for fund. The higher amount of exits for fund were in 2019. The top activity for fund was in 2016. The average startup value when the investment from Oriza Ventures is 100-500 millions dollars. This Oriza Ventures works on 23 percentage points less the average amount of lead investments comparing to the other organizations. The fund is constantly included in 2-6 deals per year.
We also calculated 2 valuable employees in our database.
Funds with similar focus
|Aiche Technology||Beijing, Beijing, China|
|alumshares||North Carolina, Raleigh, United States|
|Avera Pharmaceutical||California, Carlsbad, United States|
|Baxalta||Illinois, Illinois City, United States|
|Cazador Acquisition Corporation Ltd||Bulgaria, Grad Sofiya, Sofia|
|Circularity Capital||City of Edinburgh, Scotland, United Kingdom|
|CommIT Capital||Moscow, Moscow, Russia|
|Escondido Ventures||San Antonio, Texas, United States|
|Fresh VC||California, San Francisco, United States|
|ICS Global||Michigan, Rochester, United States|
|Muzhitong Technology||China, Hubei, Wuhan|
|Newlight Partners||New York, New York, United States|
|Splunk||California, San Francisco, United States|
|Star Power||Canada, Ontario, Toronto|
|Sycamore Ventures||New Jersey, Princeton, United States|
|Webforia||Bellevue, United States, Washington|
|$2M||07 Jun 2022||Berlin, Berlin, Germany|
|$10M||06 Apr 2022||San Francisco, California, United States|
|$12M||08 Feb 2022||San Francisco, California, United States|
|$3M||01 Dec 2021||Mountain View, California, United States|
|17 Aug 2021||Shanghai, Shanghai, China|
|$9M||17 May 2021||Palo Alto, California, United States|
|$100M||06 Apr 2021||Shanghai, China|
|$30M||23 Feb 2021||Redwood City, California, United States|
APstem Therapeutics, Inc.
|$2M||01 Sep 2020||Fremont, California, United States|
– Teon Therapeutics completed a $30m Series A financing.
– The financing was led by Oceanpine Capital with participation from additional new investors Oriza Ventures, Lifespan Investments, and former Gilead senior executives.
– All existing investors also participated in the financing round including Northern Light Venture Capital, Kaitai Capital and Oriental Fortune Capital.
– The funds will be used to advance the company’s lead A2BR-selective antagonist TT-702 into the clinic as well as to build the company’s pipeline.
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.